Client Background A fast-growing SaaS scale-up had built a category-defining software platform with a proven product-market fit and a rapidly growing customer base. Expansion opportunities were clear: new international markets, bigger enterprise deals, and an aggressive sales push. But scaling SaaS is capital-intensive. Customer acquisition costs (CAC) are front-loaded, while revenue from subscriptions trickles in…
Client Background An emerging E-Mobility company had successfully developed and launched its next-generation electric vehicle technology. With strong demand in existing markets, the company was ready to scale production and expand into new regions. However, increasing manufacturing capacity required substantial upfront investment. To avoid equity dilution and maintain operational control, the company sought €5M in…
Client Background A MedTech company developing an innovative medical device was in the final stages of regulatory approval. The next step was securing capital to complete the approval process and scale up manufacturing. The company sought €8M in non-dilutive financing to fund these milestones efficiently. Challenge / Pain Point Solution / Approach 1. Identifying the…
Client Background A MedTech startup on the verge of a breakthrough had developed a next-generation medical device designed to revolutionize patient outcomes. With strong clinical validation and early traction, the company was ready to scale—but capital constraints were slowing down product development and blocking expansion into key European markets. Challenge / Pain Point Solution /…
Client Background An AI software startup specializing in machine learning optimization sought to expand its EU presence. Despite strong technology and early traction, securing the right investors was critical to accelerating growth and executing their go-to-market strategy. Challenge / Pain Point Solution / Approach Outcome / Results Key Takeaways Looking to raise capital and scale…
Client Background A biotech scale-up developing a groundbreaking therapeutic treatment was at a pivotal stage in its growth. The company needed €7M in equity financing to advance its clinical trials and obtain regulatory approval for market entry. Despite strong scientific validation, navigating the highly specialized investor landscape was a major challenge. Challenge / Pain Points…
Convertible debt is a type of financing in which a company issues bonds or loans to investors that can be converted into equity later. This allows investors to lend money to the company while also having the option to participate in the company’s future growth by converting their debt into equity.
Asset based Financing is a type of financing that uses a company’s assets, such as inventory, accounts receivable, and fixed assets, as collateral for a loan. This type of financing can provide companies with access to capital that they may not be able to obtain through traditional forms of lending.
Silicon Valley Bank (SVB) is a financial services company that specializes in serving the needs of technology, life science, and venture capital companies. The bank was founded in 1983 and is headquartered in Santa Clara, California, in the heart of Silicon Valley.
Columbia Lake Partners (CLP) is a venture debt provider that offers growth loans to European early-stage and growth-stage technology companies. CLP also provides strategic guidance and support to its portfolio companies.
